Effect of high volume saline enemas during labour
| ISRCTN | ISRCTN43153145 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN43153145 |
| Protocol serial number | N/A |
| Sponsor | INCLEN Trust (USA) |
| Funders | International Clinical Epidemiology Network seed grant, Enemas donated by Baxter (without detailed knowledge of research protocol), Own funds provided by Luis Gabriel Cuervo, Logistics by the School of Medicine at the Universidad Javeriana in Bogota |
- Submission date
- 20/03/2002
- Registration date
- 20/03/2002
- Last edited
- 04/10/2017
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Pregnancy and Childbirth
Plain English summary of protocol
Not provided at time of registration
Contact information
Scientific
525 23rd St, NW
Washington
DC 20037-2895
United States of America
| Phone | + 1 202 974 3135 |
|---|---|
| lgcuervo@gmail.com |
Study information
| Primary study design | Interventional |
|---|---|
| Study design | Randomised controlled trial |
| Secondary study design | Randomised controlled trial |
| Scientific title | Effect of high volume saline enemas during labour: a randomised controlled trial |
| Study objectives | The main objective of this trial was to determine if the use of high volume enemas during the first stage of labour modified neonatal and/or puerperal infectious rates. The null hypothesis stated that infectious morbidity was similar for intervention and control groups. A secondary objective was to establish if there is any effect on specific neonatal or puerperal infectious rates and other clinically relevant outcomes. |
| Ethics approval(s) | Not provided at time of registration |
| Health condition(s) or problem(s) studied | Puerperal and neonatal infections |
| Intervention | Enema versus no enema. Block randomisation allocation with sealed envelopes. |
| Intervention type | Other |
| Primary outcome measure(s) |
The primary outcomes were infections in newborns and /or puerperal women. During the analysis, neonatal and puerperal infections were described individually and then amalgamated into a new outcome. This outcome was the 'combined maternal-neonatal outcome'. |
| Key secondary outcome measure(s) |
Not provided at time of registration |
| Completion date | 28/02/1998 |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Adult |
| Sex | Female |
| Target sample size at registration | 443 |
| Key inclusion criteria | 1. Women attending labour ward at low risk for delivery 2. Greater than 36 week gestation 3. In labour 4. Cervix dilatation <8 cm |
| Key exclusion criteria | Clinical diagnosis of any systemic or gynaecological bacterial infection, use of systemic antibiotics during the week prior to admission, rupture of amniotic membranes or doubt of their integrity, and a cervical dilatation greater than or equal to 7 cm. |
| Date of first enrolment | 01/02/1997 |
| Date of final enrolment | 28/02/1998 |
Locations
Countries of recruitment
- Colombia
- United States of America
Study participating centre
DC 20037-2895
United States of America
Results and Publications
| Individual participant data (IPD) Intention to share | No |
|---|---|
| IPD sharing plan summary | Not provided at time of registration |
| IPD sharing plan |
Study outputs
| Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
|---|---|---|---|---|---|
| Results article | Results | 19/03/2006 | Yes | No |
Editorial Notes
04/10/2017: internal review.